Tasly Pharmaceuticals, Inc.
19
1
1
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
5.3%
1 terminated/withdrawn out of 19 trials
90.9%
+4.4% vs industry average
26%
5 trials in Phase 3/4
10%
1 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (19)
Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina
Role: lead
Safety and Efficacy of T89 in the Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)
Role: lead
Expanded Access to T89 for Treatment Use in Intermediate-size Patients Population With COVID-19
Role: lead
Primary FIbrinolysis and Secondary STenting Versus immEdiate Stenting in ST-segment Elevation Myocardial Infarction
Role: collaborator
A Clinical Study to Evaluate the Safety and Efficacy of T92 in Pediatric Patients With Tourette Syndrome
Role: lead
Evaluate the Efficacy, Safety and Tolerability of TSUPPORT for Adults With Tourette Syndrome
Role: lead
The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19
Role: lead
Safety and Efficacy of T89 in Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)
Role: lead
Effects of Deepure(Pu-erh Tea Extract) on Glycemic Control
Role: lead
Study of Compound Danshen Dripping Pills to Treat Acute Mountain Sickness
Role: lead
Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic Retinopathy
Role: lead
A Study of Ginsenoside H Dripping Pills for Advanced Non-Small Cell Lung Cancer (NSCLC)
Role: lead
Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina
Role: lead
Dose-Escalate Study to Investigate the Safety and Tolerability of T89 in Japanese
Role: lead
Phase II Multi-Center Study of T89 to Treat Chronic Stable Angina
Role: lead
Phase III Study of 5LGr to Treat Tic Disorder
Role: lead
A Study To Evaluate The Effect of T89(Dantonic®)On P450 Enzymes
Role: lead
A Study to Evaluate the Effect of T89(Dantonic®)on Steady-State Pharmacodynamics of Warfarin
Role: lead
Trial of Tang-min-ling Pills in the Treatment of Type 2 Diabetes
Role: collaborator
All 19 trials loaded